| Drug repurposing using real-world data GSQ Tan, EK Sloan, P Lambert, CMJ Kirkpatrick, J Ilomäki Drug discovery today 28 (1), 103422, 2023 | 19 | 2023 |
| Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort study SJ Wood, J Ilomäki, J Gould, GSQ Tan, M Raven, JN Jureidini, ... Medical Journal of Australia 219 (1), 18-25, 2023 | 11 | 2023 |
| Do students' self-reflections of performance align with their graded performance in objective structured clinical exams? AS Lim, S Krishnan, G Tan, D Stewart, T Al-Diery Currents in Pharmacy Teaching and Learning 16 (8), 102097, 2024 | | 2024 |
| The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 … KED Ziser, S Wood, GSQ Tan, JI Morton, JE Shaw, JS Bell, J Ilomaki Journal of Diabetes 16 (4), e13507, 2024 | | 2024 |
| SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors GSQ Tan, JI Morton, S Wood, JE Shaw, DJ Magliano, J Ilomäki Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| COX2 inhibitor use and type 2 diabetes treatment intensification: A registry-based cohort study GSQ Tan, JI Morton, S Wood, NL Trevaskis, DJ Magliano, J Windsor, ... Diabetes Research and Clinical Practice 207, 111082, 2024 | | 2024 |
| Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer GSQ Tan, E Botteri, S Wood, EK Sloan, J Ilomäki Frontiers in Pharmacology 14, 1227330, 2023 | | 2023 |
| Using Administrative Healthcare Data to Identify Drug Repurposing Opportunities: The Example of Beta-blockers as Breast Cancer Treatment G Tan, E Botteri, S Wood, E Sloan, J Ilomaki | | 2022 |
| Drug repurposing using real-world data; a scoping review GSQ Tan, EK Sloan, P Lambert, CM Kirkpatrick, J Ilomaki PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 545-545, 2022 | | 2022 |
